NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Gan & Lee Pharmaceuticals (SHG: 603087)
603087 Technical Analysis
1.5
As on 30th Apr 2025 603087 STOCK Price closed @ 47.69 and we RECOMMEND Buy for LONG-TERM with Stoploss of 45.52 & Sell for SHORT-TERM with Stoploss of 50.94 we also expect STOCK to react on Following IMPORTANT LEVELS. |
603087STOCK Price
Open | 48.50 | Change | Price | % |
High | 48.99 | 1 Day | -0.79 | -1.63 |
Low | 47.58 | 1 Week | 3.70 | 8.41 |
Close | 47.69 | 1 Month | 2.13 | 4.68 |
Volume | 15400004 | 1 Year | 3.82 | 8.71 |
52 Week High 59.60 | 52 Week Low 33.10 |
SHG China Most Active Stocks
600705 | 3.47 | 0.29% |
600811 | 0.36 | -2.70% |
601288 | 5.42 | -3.04% |
601398 | 7.01 | -3.58% |
600777 | 3.21 | 1.26% |
600170 | 2.41 | -6.23% |
600157 | 1.34 | -0.74% |
601658 | 5.12 | -4.30% |
601988 | 5.53 | -2.98% |
600589 | 7.13 | -3.65% |
SHG China Top Gainers Stocks
SHG China Top Losers Stocks
603087 Daily Charts |
603087 Intraday Charts |
Whats New @ Bazaartrend |
603087 Free Analysis |
|
603087 Important Levels Intraday
RESISTANCE | 50.41 |
RESISTANCE | 49.54 |
RESISTANCE | 49.00 |
RESISTANCE | 48.46 |
SUPPORT | 46.92 |
SUPPORT | 46.38 |
SUPPORT | 45.84 |
SUPPORT | 44.97 |
603087 Forecast May 2025
4th UP Forecast | 86.08 |
3rd UP Forecast | 73.77 |
2nd UP Forecast | 66.16 |
1st UP Forecast | 58.55 |
1st DOWN Forecast | 36.83 |
2nd DOWN Forecast | 29.22 |
3rd DOWN Forecast | 21.61 |
4th DOWN Forecast | 9.3 |
603087 Weekly Forecast
4th UP Forecast | 54.18 |
3rd UP Forecast | 52.10 |
2nd UP Forecast | 50.81 |
1st UP Forecast | 49.53 |
1st DOWN Forecast | 45.85 |
2nd DOWN Forecast | 44.57 |
3rd DOWN Forecast | 43.28 |
4th DOWN Forecast | 41.20 |
603087 Forecast2025
4th UP Forecast | 107.04 |
3rd UP Forecast | 88.01 |
2nd UP Forecast | 76.24 |
1st UP Forecast | 64.48 |
1st DOWN Forecast | 30.9 |
2nd DOWN Forecast | 19.14 |
3rd DOWN Forecast | 7.37 |
4th DOWN Forecast | -11.66 |
Gan & Lee Pharmaceuticals ( SHG China Symbol : 603087 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
603087 Other Details
Segment | EQ | |
Market Capital | 37611950080.00 | |
Sector | Healthcare | |
Industry | Medical Instruments & Supplies | |
Offical website | > echo $website ; ?> |
603087 Address
![]() |
603087 Latest News
603087 Business Profile
Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and commercialization insulin and its analogues primarily in China. Its products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro injection; Prandilin 25, an insulin lispro; Raplin, an insulin aspart injection; and Raplin 30, an insulin aspart 30 injection, as well as medical devices. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals. in April 2005. Gan & Lee Pharmaceuticals. was founded in 1998 and is headquartered in Beijing, the People's Republic of China. Address: No. 8, Nanfeng West 1st Street, Beijing, China, 101109
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service